{"id":403422,"date":"2020-12-21T07:03:09","date_gmt":"2020-12-21T12:03:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403422"},"modified":"2020-12-21T07:03:09","modified_gmt":"2020-12-21T12:03:09","slug":"tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/","title":{"rendered":"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">IRVINE, Calif., Dec.  21, 2020  (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that it has been added to the broad-market Russell 3000<sup>\u00ae<\/sup> Index and the small-cap Russell 2000<sup>\u00ae<\/sup> Index as part of the index\u2019s quarterly initial public offering (IPO) additions.<\/p>\n<p align=\"justify\">Membership in the US all-cap Russell 3000<sup>\u00ae<\/sup> Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000<sup>\u00ae<\/sup> Index or small-cap Russell 2000<sup>\u00ae<\/sup> Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.<\/p>\n<p align=\"justify\">Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell&#8217;s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.<\/p>\n<p align=\"justify\">For more information on the Russell Indexes, please visit the \u201cRussell Reconstitution\u201d section on the FTSE Russell website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ERfHd_kZ6_dcMPOOnnPwzp8Sowwn_5HOCQpiZ43uFmp3ChxHcnI_ft3Xz1_beKWFkZAlHssScp79AoeFdS2FKY2w9DZhpjqww4miWHPl5W8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ftserussell.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Tarsus Pharmaceuticals, Inc.<\/strong><br \/>\n        <br \/>Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b\/3 that is being developed for the treatment of Demodex blepharitis.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute \u201cforward-looking statements.\u201d The words, without limitation, \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ctarget,\u201d \u201cwill\u201d or \u201cwould\u201d or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, and are detailed from time to time in the reports Tarsus files with the Securities and Exchange Commission, copies of which are posted on its website and are available from Tarsus without charge. However, new risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statements contained in this press release are based on the current expectations of Tarsus\u2019 management team and speak only as of the date hereof, and Tarsus specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Patti Bank<br \/>Westwicke Partners, an ICR company<br \/>(415) 513-1284<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8zAGMr4glR9I6uHG03rwPFp5ijcJHmJlb-Unh-Jr5ihXoJfksi8hJieArmYSJ8wXRIQtVDmg0IlYUHqAJd0V5A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">IR@tarsusrx.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Allison Howell<br \/>Pascale Communications, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UhijuUxidun0zJnWGUAfZQhHesCcTUc2s4iRNXNGJSpP5Dh3tdK3H8gJsp2DsTvF7bLxDdsFCdmp6O13DQvzOIXCKG625cL0N-K082k8aAnfncj9wt5PIIBkLR7NOUPW\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">allison@pascalecommunications.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/9b9ae56e-1707-4f96-b3c3-3d657d53d6c1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that it has been added to the broad-market Russell 3000\u00ae Index and the small-cap Russell 2000\u00ae Index as part of the index\u2019s quarterly initial public offering (IPO) additions. Membership in the US all-cap Russell 3000\u00ae Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000\u00ae Index or small-cap Russell 2000\u00ae Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403422","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that it has been added to the broad-market Russell 3000\u00ae Index and the small-cap Russell 2000\u00ae Index as part of the index\u2019s quarterly initial public offering (IPO) additions. Membership in the US all-cap Russell 3000\u00ae Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000\u00ae Index or small-cap Russell 2000\u00ae Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes &hellip; Continue reading &quot;Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-21T12:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index\",\"datePublished\":\"2020-12-21T12:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/\"},\"wordCount\":519,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/\",\"name\":\"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=\",\"datePublished\":\"2020-12-21T12:03:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/","og_locale":"en_US","og_type":"article","og_title":"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index - Market Newsdesk","og_description":"IRVINE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that it has been added to the broad-market Russell 3000\u00ae Index and the small-cap Russell 2000\u00ae Index as part of the index\u2019s quarterly initial public offering (IPO) additions. Membership in the US all-cap Russell 3000\u00ae Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000\u00ae Index or small-cap Russell 2000\u00ae Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes &hellip; Continue reading \"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-21T12:03:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index","datePublished":"2020-12-21T12:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/"},"wordCount":519,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/","name":"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=","datePublished":"2020-12-21T12:03:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTUwNSMzODkwNjIwIzIyMDM4NjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-announces-inclusion-in-the-russell-3000-index-and-russell-2000-index\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403422"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403422\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}